Becker's Healthcare July 30, 2024
Between April 2023 and March 2024, Humira accounted for top medication spend for Vizient pharmacy program participants, according to a Vizient report published July 30.
To assess medication expenditure in health systems, Vizient collected data from hospital, non-acute and pediatric care clients for its Pharmacy Market Outlook report. Medications from outsourced compounding pharmacies and 340B purchases were not included.
Here are the No. 1 medications by cost and utilization across eight service lines and therapeutic areas:
Autoimmune and inflammatory diseases: Humira (adalimumab), a medication for...
Today's Sponsors
Today's Sponsor